Sarepta therapeutics to present results from its gene therapy and rna platforms at the 2021 annual mda clinical and scientific conference

-- ten abstracts, including four podium presentations, reflect sarepta's ongoing commitment to advancing genetic medicine for rare neuromuscular disease and facilitating greater understanding of these devastating conditions -- cambridge, mass., march 15, 2021 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, will present at the muscular dystrophy association (mda) annual clinical and scientific conference, which will take place virtually march 15-18, 2021. among the research that will be presented:
SRPT Ratings Summary
SRPT Quant Ranking